A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Clinical trial NCT06010303 · COMPLETED

Trial details

NCT number: NCT06010303
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma by AJCC V8 Stage

Start date: 2023-11-08
Primary completion: 2025-05-30
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.